1. Home
  2. EVI vs SLN Comparison

EVI vs SLN Comparison

Compare EVI & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVI
  • SLN
  • Stock Information
  • Founded
  • EVI 1959
  • SLN 1994
  • Country
  • EVI United States
  • SLN United Kingdom
  • Employees
  • EVI N/A
  • SLN N/A
  • Industry
  • EVI Other Consumer Services
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVI Consumer Discretionary
  • SLN Health Care
  • Exchange
  • EVI Nasdaq
  • SLN Nasdaq
  • Market Cap
  • EVI 353.9M
  • SLN 345.3M
  • IPO Year
  • EVI N/A
  • SLN N/A
  • Fundamental
  • Price
  • EVI $22.83
  • SLN $6.80
  • Analyst Decision
  • EVI Strong Buy
  • SLN Buy
  • Analyst Count
  • EVI 1
  • SLN 6
  • Target Price
  • EVI $40.00
  • SLN $39.67
  • AVG Volume (30 Days)
  • EVI 18.5K
  • SLN 197.4K
  • Earning Date
  • EVI 11-10-2025
  • SLN 11-06-2025
  • Dividend Yield
  • EVI 1.50%
  • SLN N/A
  • EPS Growth
  • EVI N/A
  • SLN N/A
  • EPS
  • EVI 0.39
  • SLN N/A
  • Revenue
  • EVI $404,474,000.00
  • SLN $25,830,000.00
  • Revenue This Year
  • EVI $14.10
  • SLN N/A
  • Revenue Next Year
  • EVI $4.00
  • SLN N/A
  • P/E Ratio
  • EVI $56.28
  • SLN N/A
  • Revenue Growth
  • EVI 12.63
  • SLN 40.39
  • 52 Week Low
  • EVI $14.99
  • SLN $1.97
  • 52 Week High
  • EVI $34.82
  • SLN $15.25
  • Technical
  • Relative Strength Index (RSI)
  • EVI 31.26
  • SLN 55.16
  • Support Level
  • EVI $24.98
  • SLN $5.80
  • Resistance Level
  • EVI $29.36
  • SLN $6.78
  • Average True Range (ATR)
  • EVI 1.53
  • SLN 0.52
  • MACD
  • EVI -0.52
  • SLN -0.06
  • Stochastic Oscillator
  • EVI 1.09
  • SLN 58.99

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: